carbapenems has been researched along with Renal Insufficiency, Chronic in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (60.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
Authors | Studies |
---|---|
Armiñanzas-Castillo, C; Bahamonde-Carrasco, A; Boix-Palop, L; Cuquet-Pedragosa, J; Del Arco-Jiménez, A; Fernández-Natal, I; Fernandez-Suarez, J; Galan-Sanchez, F; Goikoetxea-Aguirre, AJ; Jóver-Saenz, A; León Jiménez, E; Lopez-Cortes, LE; López-Hernández, I; Martínez Pérez-Crespo, PM; Morán Rodríguez, MÁ; Mussa, M; Reguera-Iglesias, JM; Retamar-Gentil, P; Rodríguez-Baño, J; Sánchez-Calvo, JM; Sánchez-Porto, A; Smithson-Amat, A; Sousa-Dominguez, A; Vinuesa-García, D | 1 |
Arimuthu, DA; Mazlan, SA; Shahar, S | 1 |
Abbasi, SA; Ahmed, A; Bokhari, H; Hussain, Z; Imran, M; Jamil, B; Mukhtar Bokhari, MT; Mukhtar Bokhari, MZ; Saeed, A | 1 |
Chen, TY; Dubrovskaya, Y; Esaian, D; Mehta, SA; Papadopoulos, J; Phillips, MS; Scipione, MR | 1 |
Chang, CM; Chen, PL; Ko, WC; Lee, CC; Lee, NY; Li, CW; Li, MC | 1 |
5 other study(ies) available for carbapenems and Renal Insufficiency, Chronic
Article | Year |
---|---|
Risk Factors and Predictive Score for Bacteremic Biliary Tract Infections Due to Enterococcus faecalis and Enterococcus faecium: a Multicenter Cohort Study from the PROBAC Project.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Biliary Tract; Carbapenems; Cholangiocarcinoma; Cholangitis; Cohort Studies; Enterococcus; Enterococcus faecalis; Enterococcus faecium; Gram-Positive Bacterial Infections; Humans; Renal Insufficiency, Chronic; Risk Factors | 2022 |
Ertapenem-induced neurotoxicity in an end-stage renal disease patient on intermittent haemodialysis: a case report.
Topics: Anti-Bacterial Agents; beta-Lactams; Carbapenems; Ertapenem; Humans; Kidney Failure, Chronic; Male; Middle Aged; Neurotoxicity Syndromes; Renal Dialysis; Renal Insufficiency, Chronic | 2022 |
Multidrug resistance in Gram-negative pathogens isolated from patients with chronic kidney diseases and renal transplant.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Cross-Sectional Studies; Drug Resistance, Multiple, Bacterial; Escherichia coli; Fluoroquinolones; Gram-Negative Bacteria; Humans; Kidney Transplantation; Klebsiella pneumoniae; Renal Insufficiency, Chronic | 2018 |
Risk factors for treatment failure of polymyxin B monotherapy for carbapenem-resistant Klebsiella pneumoniae infections.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Drug Resistance, Multiple, Bacterial; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Logistic Models; Male; Microbial Sensitivity Tests; Middle Aged; Polymyxin B; Renal Insufficiency, Chronic; Retrospective Studies; Risk Factors; Survival Analysis; Treatment Failure | 2013 |
Cefepime Therapy for Monomicrobial Enterobacter cloacae Bacteremia: Unfavorable Outcomes in Patients Infected by Cefepime-Susceptible Dose-Dependent Isolates.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cefepime; Cephalosporins; Diabetes Complications; Diabetes Mellitus; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Gene Expression; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Neoplasms; Renal Insufficiency, Chronic; Retrospective Studies; Severity of Illness Index; Survival Analysis; Treatment Outcome | 2015 |